Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;8(5):e70103.
doi: 10.1002/edm2.70103.

Trifolium pratense-Derived Exosome Improved Serum Biochemical Parameters and Pancreatic Genes in STZ-Induced Diabetic Rats

Affiliations

Trifolium pratense-Derived Exosome Improved Serum Biochemical Parameters and Pancreatic Genes in STZ-Induced Diabetic Rats

Amir Hossein Khazaei et al. Endocrinol Diabetes Metab. 2025 Sep.

Abstract

Introduction: Plant-derived exosomes (PDEs) are promising nanotherapeutics for improving chronic diseases, such as diabetes mellitus. Trifolium pratense (TP) is a flowering herb with potent antioxidant and antidiabetic properties. The present study aimed to explore the diabetic-healing effects of TP-derived exosomes (TPDEs) in streptozotocin (STZ)-induced diabetic rats.

Methods: TPDEs were isolated using polyethylene glycol precipitation and serial centrifugation and characterised. STZ-induced diabetic rats were treated with TPDE doses (0, 100, 200, and 400 μg/kg) for 28 days. Biochemical factors (fasting blood sugar (FBS), insulin, C-peptide, total antioxidant capacity (TAC), and nitric oxide (NO)) were evaluated in serum samples. Also, the expression of PDX1, insulin, NGN3, and SIRT1 genes in pancreas tissues was assessed using real-time PCR.

Results: TPDE treatment decreased the serum levels of FBS and NO while increasing c-peptide, insulin, and TAC levels. It also significantly enhanced the expression of insulin, PDX1, NGN3, and SIRT1 genes. TPDEs at doses of 100 to 200 μg/kg showed the most significant antidiabetic effects.

Conclusion: TPDEs significantly improved diabetes-induced alterations in serum insulin levels, antioxidant status, and pancreas-related gene expression. It can be considered a novel complementary treatment for diabetes.

Keywords: Trifolium pratense; diabetes; plant‐derived exosomes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
T. pratense fresh plant. (A) Before harvesting; (B) Cleaned aerial parts.
FIGURE 2
FIGURE 2
Characterisation of TPDE. (A) TPDEs participated using PEG; (B) DLS data; (C) Zeta potential data. DLS, dynamic light scattering; PEG, polyethylene glycol; TPDE, T. pratense ‐derived exosome.
FIGURE 3
FIGURE 3
The analysis of FBS and body weight in healthy (control) and STZ‐induced diabetic rats treated with TPDEs. (A) FBS; (B) Body weight. Different letters indicate significant differences between groups. B, body weight; FBS, fasting blood sugar. (a, b: p < 0.001, c, d: p < 0.05, ac: no significant differences with a and c, ns: non‐significant).
FIGURE 4
FIGURE 4
The analysis of NO and TAC in healthy (control) and STZ‐induced diabetic rats treated with TPDEs. (A) NO; (B) TAC. Different letters indicate significant differences between groups. NO, nitric oxide; TAC, total antioxidant capacity (a, b: p < 0.05, c, d: p < 0.001, ab: no significant differences with a and b, ns: non‐significant).
FIGURE 5
FIGURE 5
The analysis of insulin and C‐C‐peptide in healthy (control) and STZ‐induced diabetic rats treated with TPDEs. (A) Insulin; (B) C‐C‐peptide. Different letters indicate significant differences between groups (a, b, c: p < 0.001, ac: no significant differences with a and c).
FIGURE 6
FIGURE 6
The expression of PDX1, insulin, NGN3, and SIRT1 in pancreas tissue of healthy (control) and STZ‐induced diabetic rats treated with TPDEs. (A) PDX1, (B) Insulin, (C) NGN3; (D) SIRT1. NGN3, Neurogenin 3; PDX1, pancreatic and duodenal homeobox 1; SIRT1, Sirtuin 1. (a: p < 0.05, b–e: p < 0.001).

Similar articles

References

    1. Sun H., Saeedi P., Karuranga S., et al., “IDF Diabetes Atlas: Global, Regional and Country‐Level Diabetes Prevalence Estimates for 2021 and Projections for 2045,” Diabetes Research and Clinical Practice 183 (2022): 109119, 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Dilworth L., Facey A., and Omoruyi F., “Diabetes Mellitus and Its Metabolic Complications: The Role of Adipose Tissues,” International Journal of Molecular Sciences 22 (2021): 7644, 10.3390/ijms22147644. - DOI - PMC - PubMed
    1. Omar N., Nazirun N. N., Vijayam B., Wahab A. A., and Bahuri H. A., “Diabetes Subtypes Classification for Personalized Health Care: A Review,” Artificial Intelligence Review 56 (2023): 2697–2721, 10.1007/s10462-022-10202-8. - DOI
    1. Padgett L. E., Broniowska K. A., Hansen P. A., Corbett J. A., and Tse H. M., “The Role of Reactive Oxygen Species and Proinflammatory Cytokines in Type 1 Diabetes Pathogenesis,” Annals of the New York Academy of Sciences 1281 (2013): 16–35, 10.1111/j.1749-6632.2012.06826.x. - DOI - PMC - PubMed
    1. Lima J. E., Moreira N. C., and Sakamoto‐Hojo E. T., “Mechanisms Underlying the Pathophysiology of Type 2 Diabetes: From Risk Factors to Oxidative Stress, Metabolic Dysfunction, and Hyperglycemia,” Mutation Research/Genetic Toxicology and Environmental Mutagenesis 874 (2022): 503437, 10.1016/j.mrgentox.2021.503437. - DOI - PubMed

MeSH terms

LinkOut - more resources